African trypanosomiasis
Pathogen, epidemiology, transmission
Tsetse fly
Trypanosoma brucei gambiense (West/central Africa, majority of cases, more chronic) - anthroponotic
Trypanosoma brucei rhodesiense (East/Southern Africa, minority of cases, more acute); animal reservoir (zoonotic)
Only Uganda has both gambiense and rhodesiense
Clinical
Chancre (primary stage), acute haemolytic stage, chronic meningoencephalitic phase
Rhodiense
Chancre (2-14 days)
1. Hemolymphatic stage (days-weeks): fever, malaise, anemia, macular rash, lymphadenopathy, myopericarditis
2. Meningoencephalitic stage (weeks): sleep disturbances, tremor, ataxia, somnolence, coma, death
Gambiense
Hemolymphatic stage (weeks-months-years): relapsing fever, lymphadenopathy, hepatosplenomegaly, pruritus, edema
Meningoencephalitic stage (months/years): insomnia, sleep disturbances, personality changes, tremor, ataxia, motor weakness, somnolence, coma, death
Diagnosis
General
Can see abnormal LFTs and pancytopenia (bone marrow)
Parasitological/microscopic
trypanosomes (blood, lymph node, CSF (stage 2)
Antibody detection
Antibodies to trypanosoma brucei gambiense in blood/serum/plasma (HAT sero K-Set)
Card agglutination test (CATT), for population screening
Nucleic acid detection
PCR or LAMP
Lumbar puncture; centrifuge CSF (WBC, Morula cells?, microscopy for trypanosomes)
Treatment
Gambiense
Fexinidazole (won't need to do LPs), PO for 14 days (cure rate
Stage 1: Pentamidine
Stage 2: Nifurtimox-efloornithine (NECT)
Rhodiense
Stage 1 (blood stage): Suramin
Stage 2 (CNS): Melarsoprol (risk of post-treatment reactive encephalopathy)
Fexinidazole not tested yet in Rhodiense, less common
Bailey slides below: